116 related articles for article (PubMed ID: 3080008)
1. Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine.
Bitonti AJ; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1986 Jan; 35(2):331-4. PubMed ID: 3080008
[TBL] [Abstract][Full Text] [Related]
2. Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy.
de Gee AL; McCann PP; Mansfield JM
J Parasitol; 1983 Oct; 69(5):818-22. PubMed ID: 6423794
[TBL] [Abstract][Full Text] [Related]
3. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
4. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
[TBL] [Abstract][Full Text] [Related]
5. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
[TBL] [Abstract][Full Text] [Related]
6. Curative effect of alpha-difluoromethylornithine on fatal Trypanosoma congolense infection in mice.
Karbe E; Böttger M; McCann PP; Sjoerdsma A; Freitas EK
Tropenmed Parasitol; 1982 Sep; 33(3):161-2. PubMed ID: 6814025
[TBL] [Abstract][Full Text] [Related]
7. Physiological activation of the mitochondrion and the transformation capacity of DFMO induced intermediate and short stumpy bloodstream form trypanosomes.
Giffin BF; McCann PP
Am J Trop Med Hyg; 1989 May; 40(5):487-93. PubMed ID: 2499202
[TBL] [Abstract][Full Text] [Related]
8. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.
Van Nieuwenhove S; Schechter PJ; Declercq J; Boné G; Burke J; Sjoerdsma A
Trans R Soc Trop Med Hyg; 1985; 79(5):692-8. PubMed ID: 3938090
[TBL] [Abstract][Full Text] [Related]
9. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes in Trypanosoma brucei rhodesiense following inhibition of polyamine biosynthesis in vivo.
de Gee AL; Carstens PH; McCann PP; Mansfield JM
Tissue Cell; 1984; 16(5):731-8. PubMed ID: 6440309
[TBL] [Abstract][Full Text] [Related]
11. Polyamine metabolism: a potential therapeutic target in trypanosomes.
Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
[TBL] [Abstract][Full Text] [Related]
12. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
[TBL] [Abstract][Full Text] [Related]
13. Antagonism by polyamines of the curative effects of alpha-difluoromethylornithine in Trypanosoma brucei brucei infections.
Nathan HC; Bacchi CJ; Hutner SH; Rescigno D; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1981 Nov; 30(21):3010-3. PubMed ID: 6797437
[No Abstract] [Full Text] [Related]
14. Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.
Bacchi CJ; Berens RL; Nathan HC; Klein RS; Elegbe IA; Rao KV; McCann PP; Marr JJ
Antimicrob Agents Chemother; 1987 Sep; 31(9):1406-13. PubMed ID: 3118799
[TBL] [Abstract][Full Text] [Related]
15. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei.
Demey F
Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883
[TBL] [Abstract][Full Text] [Related]
16. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
Jennings FW
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
Milord F; Pépin J; Loko L; Ethier L; Mpia B
Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients].
Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491
[TBL] [Abstract][Full Text] [Related]
19. Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis.
Bitonti AJ; Bacchi CJ; McCann PP; Sjoerdsma A
Biochem Pharmacol; 1985 May; 34(10):1773-7. PubMed ID: 3924048
[TBL] [Abstract][Full Text] [Related]
20. Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model.
Loiseau PM; Czok M; Chauffert O; Bourass J; Letourneux Y
Parasite; 1998 Sep; 5(3):239-46. PubMed ID: 9772723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
